[1] |
Harada K,Rogers JE,Iwatsuki M,et al.Recent advances in treating oesophageal cancer[J].F1000Res,2020(9):F1000 Facutty Rev-1189.DOI:10.12688/f1000research.22926.1.
|
[2] |
Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263.DOI:10.3322/caac.21834.
|
[3] |
张希,杨雷,刘硕,等.2022 年全球恶性肿瘤统计报告解读[J].中华肿瘤杂志,2024,46(7):710-721.DOI:10.3760/cma.j.cn112152-20240416-00152.
|
[4] |
Qi JH,Huang SL,Jin SZ.Novel milestones for early esophageal carcinoma:from bench to bed[J].World J Gastrointest Oncol,2024,16(4):1104-1118.DOI:10.4251/wjgo.v16.i4.1104.
|
[5] |
Liang H,Fan JH,Qiao YL.Epidemiology,etiology,and prevention of esophageal squamous cell carcinoma in China[J].Cancer Biol Med,2017,14(1):33-41.DOI:10.20892/j.issn.2095-3941.2016.0093.
|
[6] |
上海国家消化系统疾病临床医学研究中心,中华医学会消化内镜学分会,中国医师协会内镜医师分会消化内镜专业委员会,等.中国食管鳞癌癌前状态及癌前病变诊治策略专家共识[J].中华消化内镜杂志,2020,37(12):853-867.DOI:10.3760/cma.j.cn321463-20200928-00807.
|
[7] |
Wen T,Wang W,Chen X.Recent advances in esophageal squamous cell precancerous conditions:a review[J].Medicine (Baltimore),2022,101(50):e32192.DOI:10.1097/MD.0000000000032192.
|
[8] |
邢洁,李鹏.早期食管鳞状细胞癌及癌前病变的诊断与治疗策略[J].中华内科杂志,2020,59(4):318-321.DOI:10.3760/cma.j.cn112138-20200210-00061.
|
[9] |
Chu LY,Peng YH,Weng XF,et al.Blood-based biomarkers for early detection of esophageal squamous cell carcinoma[J].World J Gastroenterol,2020,26(15):1708-1725.DOI:10.3748/wjg.v26.i15.1708.
|
[10] |
Chen ZB,Xing J,Zheng CL,et al.Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection[J].Front Oncol,2023(13):1161489.DOI:10.3389/fonc.2023.1161489.
|
[11] |
杨时煌,罗育豪,翁雪芬,等.血清p53 自身抗体在乳腺癌中的诊断价值[J].中国老年学杂志,2018,38(14):3373-3375.DOI:10.3969/j.issn.1005-9202.2018.14.017.
|
[12] |
Yasuda M,Kuwano H,Watanabe M,et al.p53 expression in squamous dysplasia associated with carcinoma of the oesophagus:evidence for field carcinogenesis[J].Br J Cancer,2000,83(8):1033-1038.DOI:10.1054/bjoc.2000.1443.
|
[13] |
Sabapathy K,Lane DP.Understanding p53 functions through p53 antibodies[J].J Mol Cell Biol,2019,11(4):317-329.DOI:10.1093/jmcb/mjz010.
|
[14] |
Krothapalli M,Kini JR,Kini H,et al.Evaluation of p53 protein expression in Barrett esophagus[J].Indian J Pathol Microbiol,2018,61(2):170-175.DOI:10.4103/IJPM.IJPM_369_16.
|
[15] |
Wang LD,Hong JY,Qiu SL,et al.Accumulation of p53 protein in human esophageal precancerous lesions:a possible early biomarker for carcinogenesis[J].Cancer Res,1993,53(8):1783-1787.
|
[16] |
Lingle WL,Barrett SL,Negron VC,et al.Centrosome amplification drives chromosomal instability in breast tumor development[J].Proc Natl Acad Sci U S A,2002,99(4):1978-1983.DOI:10.1073/pnas.032479999.
|
[17] |
Li Q,Wang J,Ma XD,et al.POFUT1 acts as a tumor promoter in glioblastoma by enhancing the activation of Notch signaling[J].J Bioenerg Biomembr,2021,53 (5): 621-632.DOI: 10.1007/s10863-021-09912-5.
|
[18] |
Xu YW,Peng YH,Chen B,et al.Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma[J].Am J Gastroenterol,2014,109(1):36-45.DOI:10.1038/ajg.2013.384.
|
[19] |
林琳,曹伟娟.p53 抗体、miR-451、CYFRA21-1、CEA 联合检测对食管鳞状细胞癌的诊断价值[J].河南医学高等专科学校学报,2023,35(5):548-551.DOI:10.3969/j.issn.1008-9276.2023.05.018.
|
[20] |
Zhou SL,Yue WB,Fan ZM,et al.Autoantibody detection to tumorassociated antigens of P53,IMP1,P16,cyclin B1,P62,C-myc,Survivn,and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma[J].Dis Esophagus,2014,27(8):790-797.DOI:10.1111/dote.12145.
|
[21] |
Nicholson JK,Lindon JC,Holmes E.'Metabonomics':understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data[J].Xenobiotica,1999,29(11):1181-1189.DOI:10.1080/004982599238047.
|
[22] |
Anwardeen NR,Diboun I,Mokrab Y,et al.Statistical methods and resources for biomarker discovery using metabolomics[J].BMC Bioinformatics,2023,24(1):250.DOI:10.1186/s12859-023-05383-0.
|
[23] |
Zhang S,Lu X,Hu CX,et al.Serum metabolomics for biomarker screening of esophageal squamous cell carcinoma and esophageal squamous dysplasia using gas chromatography-mass spectrometry[J].ACS Omega,2020,5 ( 41): 26402-26412.DOI: 10.1021/acsomega.0c02600.
|
[24] |
徐小梦,孔祥图,于慧,等.基于液相色谱-质谱技术的多发性骨髓瘤患者血清代谢组学分析[J].中国实验血液学杂志,2021,29(2):520-524.DOI:10.19746/j.cnki.issn1009-2137.2021.02.033.
|
[25] |
Yang QJ,Zhao JR,Hao J,et al.Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia[J].J Cachexia Sarcopenia Muscle,2018,9(1):71-85.DOI:10.1002/jcsm.12246.
|
[26] |
Zhu ZJ,Qi Z,Zhang J,et al.Untargeted metabolomics analysis of esophageal squamous cell carcinoma discovers dysregulated metabolic pathways and potential diagnostic biomarkers [J].J Cancer,2020,11(13):3944-3954.DOI:10.7150/jca.41733.
|
[27] |
Yang ZX,Liu YY,Ma LM,et al.Exploring potential biomarkers of early stage esophageal squamous cell carcinoma in pre- and postoperative serum metabolomic fingerprint spectrum using (1)H-NMR method[J].Am J Transl Res,2019,11(2):819-831.
|
[28] |
Liu M,Tian H,Wang M,et al.Construction and validation of serum Metabolic Risk Score for early warning of malignancy in esophagus[J].iScience,2024,27(6):109965.DOI:10.1016/j.isci.2024.109965.
|
[29] |
Li X,Zhao LH,Wei MK,et al.Serum metabolomics analysis for the progression of esophageal squamous cell carcinoma[J].J Cancer,2021,12(11):3190-3197.DOI:10.7150/jca.54429.
|
[30] |
Yu MJ,Wen W,Yi X,et al.Plasma metabolomics reveals diagnostic biomarkers and risk factors for esophageal squamous cell carcinoma[J].Front Oncol,2022(12):829350.DOI:10.3389/fonc.2022.829350.
|
[31] |
Zhao C,Zhang H,Zhou JJ,et al.Metabolomic transition trajectory and potential mechanisms of N-nitrosomethylbenzylamine induced esophageal squamous cell carcinoma in rats[J].Ecotoxicol Environ Saf,2022(244):114071.DOI:10.1016/j.ecoenv.2022.114071.
|
[32] |
Che JJ,Zhao YB,Gu BB,et al.Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer[J].BMC Cancer,2023,23(1):1238.DOI:10.1186/s12885-023-11744-y.
|
[33] |
Yang X,Tang Z,Li J,et al.Esophagus cancer and essential trace elements[J].Front Public Health,2022(10):1038153.DOI:10.3389/fpubh.2022.1038153.
|
[34] |
Wang NN,Pan D,Zhu XP,et al.Selenium may be involved in esophageal squamous cancer prevention by affecting GPx3 and FABP1 expression:a case-control study based on bioinformatic analysis[J].Nutrients,2024,16(9).DOI:10.3390/nu16091322.
|
[35] |
Pan D,Wang SK,Su M,et al.Vitamin B(12) may play a preventive role in esophageal precancerous lesions:a case-control study based on markers in blood and 3-day duplicate diet samples[J].Eur J Nutr,2021,60(6):3375-3386.DOI:10.1007/s00394-021-02516-0.
|
[36] |
Pan D,Su M,Xu DF,et al.Exploring the interplay between vitamin b(12)-related biomarkers,DNA methylation,and gene-nutrition interaction in esophageal precancerous lesions[J].Arch Med Res,2023,54(7):102889.DOI:10.1016/j.arcmed.2023.102889.
|
[37] |
Liu CM,Liang D,Jin J,et al.Research progress on the relationship between zinc deficiency,related microRNAs,and esophageal carcinoma[J].Thorac Cancer,2017,8(6):549-557.DOI:10.1111/1759-7714.12493.
|
[38] |
Taccioli C,Chen H,Jiang Y,et al.Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature[J].Oncogene,2012,31(42):4550-4558.DOI:10.1038/onc.2011.592.
|
[39] |
Taccioli C,Wan SG,Liu CG,et al.Zinc replenishment reverses overexpression of the proinflammatory mediator S100A8 and esophageal preneoplasia in the rat[J].Gastroenterology,2009,136(3):953-966.DOI:10.1053/j.gastro.2008.11.039.
|
[40] |
Meng C,Bai C,Brown TD,et al.Human gut microbiota and gastrointestinal cancer[J].Genomics Proteomics Bioinformatics,2018,16(1):33-49.DOI:10.1016/j.gpb.2017.06.002.
|
[41] |
Liu Y,Baba Y,Ishimoto T,et al.Gut microbiome in gastrointestinal cancer:a friend or foe? [J].Int J Biol Sci,2022,18(10):4101-4117.DOI:10.7150/ijbs.69331.
|
[42] |
Jiang ZD,Wang J,Shen ZY,et al.Characterization of esophageal microbiota in patients with esophagitis and esophageal squamous cell carcinoma [J].Front Cell Infect Microbiol,2021 (11):774330.DOI:10.3389/fcimb.2021.774330.
|
[43] |
Li MJ,Shao DT,Fan ZY,et al.Non-invasive early detection on esophageal squamous cell carcinoma and precancerous lesions by microbial biomarkers combining epidemiological factors in China[J].J Gastroenterol,2024,59(7):531-542.DOI:10.1007/s00535-024-02117-8.
|
[44] |
Li MJ,Shao DT,Zhou JC,et al.Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma[J].Chin J Cancer Res,2020,32(6):755-767.DOI:10.21147/j.issn.1000-9604.2020.06.09.
|
[45] |
Berman JJ,Albores-Saavedra J,Bostwick D,et al.Precancer: a conceptual working definition-results of a consensus conference[J].Cancer Detect Prev,2006,30(5):387-394.DOI:10.1016/j.cdp.2006.09.002.
|
[46] |
高山,季坤,赵丽,等.食管鳞状上皮内瘤变的研究进展[J].实用医学杂志,2024,40(3):432-438.DOI:10.3969/j.issn.1006-5725.2024.03.027.
|
[47] |
徐玥,廖应英,孙泽群.食管癌的流行病学特征及发病高危因素研究进展[J].中国现代医生,2024,62(7):113-117.DOI:10.3969/j.issn.1673-9701.2024.07.027.
|
[48] |
Rapozo DC,Blanco TC,Reis BB,et al.Recurrent acute thermal lesion induces esophageal hyperproliferative premalignant lesions in mice esophagus[J].Exp Mol Pathol,2016,100(2):325-331.DOI:10.1016/j.yexmp.2016.02.005.
|
[49] |
Lander S,Lander E,Gibson MK.Esophageal cancer:overview,risk factors,and reasons for the rise[J].Curr Gastroenterol Rep,2023,25(11):275-279.DOI:10.1007/s11894-023-00899-0.
|
[50] |
Li P,Jing J,Liu WJ,et al.Spatiotemporal patterns of esophageal cancer burden attributable to behavioral,metabolic,and dietary risk factors from 1990 to 2019:longitudinal observational study[J].JMIR Public Health Surveill,2023(9):e46051.DOI:10.2196/46051.
|
[51] |
Aversa J,Song M,Shimazu T,et al.Prediagnostic circulating inflammation biomarkers and esophageal squamous cell carcinoma:a case-cohort study in Japan[J].Int J Cancer,2020,147(3):686-691.DOI:10.1002/ijc.32763.
|
[52] |
Han LH,Song QX,Jia YB,et al.The clinical significance of systemic inflammation score in esophageal squamous cell carcinoma[J].Tumour Biol,2016,37(3):3081-3090.DOI:10.1007/s13277-015-4152-1.
|
[53] |
Wang X,Li TT,Li HR,et al.Association of dietary inflammatory potential with blood inflammation:the prospective markers on mild cognitive impairment[J].Nutrients,2022,14(12).DOI:10.3390/nu14122417.
|
[54] |
Dong JW,Gao M,Li L,et al.Associations of dietary inflammatory potential with esophageal precancerous lesions and esophageal squamous-cell cancer:a cross-sectional study[J].Nutrients,2023,15(18).DOI:10.3390/nu15184078.
|
[55] |
Li S,Ye J,Lin Z,et al.Dietary inflammatory nutrients and esophageal squamous cell carcinoma risk:a case-control study[J].Nutrients,2022,14(23):5197.DOI:10.3390/nu14235179.
|
[56] |
林培中,张金生,戎振鹏,等.食管癌前病变的药物阻断性治疗-抗癌乙片、维胺酯和核黄素三年和五年的阻断效果[J].中国医学科学院学报,1990(4):235-245.
|
[57] |
Shi HJ,Chen XY,Chen XR,et al.Chinese Medicine formula siwuyin inhibits esophageal precancerous lesions by improving intestinal flora and macrophage polarization [J].Front Pharmacol,2022(13):812386.DOI:10.3389/fphar.2022.812386.
|
[58] |
樊李妍,范修琦,韩懿存,等.六君子汤治疗食管癌的研究进展[J].中医学报,2024,39(4):765-772.DOI:10.16368/j.issn.1674-8999.2024.04.130.
|
[59] |
田晶晶,袁红霞,张月林,等.基于Caspase-3/Bcl-2/Bax 信号通路探究加味旋覆代赭汤治疗食管癌前病变的作用机制[J].中国中西医结合外科杂志,2024,30(2):258-264.DOI:10.3969/j.issn.1007-6948.2024.02.022.
|
[60] |
Kresty LA,Morse MA,Morgan C,et al.Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries[J].Cancer Res,2001,61(16):6112-6119.
|
[61] |
Kresty LA,Frankel WL,Hammond CD,et al.Transitioning from preclinical to clinical chemopreventive assessments of lyophilized black raspberries:interim results show berries modulate markers of oxidative stress in Barrett's esophagus patients[J].Nutr Cancer,2006,54(1):148-156.DOI:10.1207/s15327914nc5401_15.
|
[62] |
Shi N,Chen F,Zhang XL,et al.Suppression of oxidative stress and NF-κB/MAPK signaling by lyophilized black raspberries for esophageal cancer prevention in rats[J].Nutrients,2017,9(4):413.DOI:10.3390/nu9040413.
|
[63] |
Jiang YX,Chen Y,Sun HH,et al.Effects of cyclooxygenase-2 inhibitors on gastrointestinal malignancies:a systematic review and meta-analysis[J].Indian J Surg Oncol,2022,13(2):348-355.DOI:10.1007/s13193-022-01547-1.
|
[64] |
吕学宁,杨炳银,宗君,等.二甲双胍抑制食管癌前病变中HIF-1α 和p53 的表达[J].现代肿瘤医学,2022,30(20):3703-3709.DOI:10.3969/j.issn.1672-4992.2022.20.013.
|